
On this page
Published:
Key Takeaways
- Small hospital cybersecurity priorities should follow clinical dependence, exposed interfaces, and available downtime procedures.
- HHS Cybersecurity Performance Goals are voluntary; they are not an FDA submission checklist or a substitute for HIPAA obligations.
- Hospitals need device-specific support, connectivity, patching, and recovery information from manufacturers.
- Medical device segmentation and remote access changes need clinical coordination and manufacturer-supported configurations.
- FDA cybersecurity evidence and hospital procurement evidence overlap, but they serve different decisions.
Cybersecurity for small hospitals should protect clinical services before adding more security tools. For connected medical devices, start with an inventory, manufacturer-supported network controls, restricted service access, and a downtime plan. Ask suppliers for security instructions, release-specific component information, and vulnerability contacts. HHS guidance supports hospital cyber resilience; FDA cybersecurity duties apply to relevant device manufacturers and submissions. A hospital security review and an FDA submission are different activities with different owners.
A bedside monitor can be working while its connection to a central station has failed. A diagnostic instrument can finish a run while the hospital cannot trust the result transfer. Cybersecurity planning needs to cover the clinical workflow, not just whether a device turns on.
Cybersecurity for small hospitals has a practical constraint: the same people may manage networks, supplier calls, and incident response. Device controls must be understandable and supportable by that team.
The FDA's Cybersecurity in Medical Devices: Quality Management System Considerations and Content of Premarket Submissions informs what manufacturers should design and document. HHS's healthcare cybersecurity resources address the organizations using those products.
This distinction matters during purchasing, installation, and maintenance. Manufacturers should explain the conditions their product needs. Hospitals should compare those conditions with their actual environment and clinical capacity. Neither side can replace that review with a certification logo or a generic questionnaire response.
Why This Matters
Device availability is only part of patient safety. A security event can interrupt alarms, alter information used for treatment, or block a clinical team's access to results. The safety consequence depends on the device, the workflow, and available alternatives.
HHS's Health Industry Cybersecurity Practices, 2023 edition, organizes its recommendations into 10 cybersecurity practices, including medical device security. Its Technical Volume 1 for small healthcare organizations addresses asset management, network management, vulnerability management, and incident response. That is a sourced count of practices, not a claim about attack rates or a required number of hospital controls.
The FDA's Cybersecurity in Medical Devices: Quality Management System Considerations and Content of Premarket Submissions, February 3, 2026, addresses manufacturer design and submission evidence. It does not assign the hospital responsibility for preparing a manufacturer's premarket file.
IEC 80001-1 supports risk management for connected health IT systems. ISO 14971 addresses medical device safety risk management, while IEC 81001-5-1 addresses health software security activities. Their roles differ; citing a standard does not prove that a particular network or product is safe.
The useful question is operational: can the supplier and hospital show who will maintain each control and what happens when it fails? A small team benefits from fewer unsupported assumptions, not from an oversized document package that hides those decisions.
What Should a Small Hospital Put in Its Device Inventory?
The inventory should connect each device to an owner, a clinical purpose, and a support decision. A purchasing list alone does not identify which products depend on a server, cloud service, or remote maintenance connection.
Record the manufacturer, model, installed software or firmware release, location, clinical owner, and technical owner. Include network interfaces, connected servers, supplier contacts, and documented support dates when available. Treat unknown fields as open questions rather than filling them with guesses.
Add a clinical dependency note. Does a failed central station interrupt observation? Can staff obtain results locally if an interface engine is unavailable? Who authorizes a device's removal from service?
| Inventory field | Why the hospital needs it | Evidence to request |
|---|---|---|
| Installed release | Vulnerability applicability depends on version | Device release record and supplier advisory |
| Required connections | Segmentation can break clinical integration | Port, protocol, and destination documentation |
| Support status | An unsupported component changes maintenance options | Supplier support statement |
| Remote service path | External access creates another trust boundary | Access architecture and service procedure |
| Recovery owner | Clinical and technical recovery are different tasks | Downtime procedure and restoration instructions |
An SBOM supports component identification. It does not replace this inventory or tell the hospital whether a device is clinically interchangeable with another product.
Which HHS Goals Help Hospitals Prioritize Device Security?
HHS's Healthcare and Public Health Cybersecurity Performance Goals provide a voluntary prioritization framework. They cover subjects such as known vulnerabilities, multifactor authentication, supplier requirements, incident planning, and network segmentation.
Apply those goals to the device's actual environment. Protect administrative and supplier access where supported. Remove unnecessary exposure. Establish a process for reviewing manufacturer notices instead of reacting only when a scanner reports a high score.
HHS performance goals are voluntary recommendations. HIPAA Security Rule obligations, contracts, state requirements, and manufacturer instructions need separate applicability reviews. Do not label the goals themselves as mandatory FDA hospital controls.
A hospital may be unable to install an endpoint agent on a medical device. That does not justify ignoring the device. It means the team needs manufacturer-supported controls around it, such as access restrictions, monitored network paths, and an approved recovery procedure.
Choose controls that the hospital can maintain. A segmentation rule without an owner, change record, or clinical test plan can fail quietly after a network change. A named owner and a verified configuration are more useful than a claim that every device is isolated.
How Can Hospitals Segment Devices Without Interrupting Care?
Start with the manufacturer's required communication paths and the clinical workflow. Then limit unnecessary connections while preserving the paths needed for treatment, alarms, results, updates, and support.
A VLAN name does not demonstrate isolation. Review the routing and firewall rules between the device, clinical applications, service infrastructure, and outside destinations. Document both allowed connections and the reason for allowing them.
Coordinate changes with clinical engineering, IT, the clinical owner, and the manufacturer. Use a controlled setting or approved maintenance window. Verify alarm delivery, result transfer, time synchronization, and recovery behavior where they are relevant.
This is a hospital change-control activity, not a recommendation to run attack tools against equipment treating patients. Security testing should use an authorized scope and appropriate nonclinical equipment or environment.
For the wider network-risk context, see IEC 80001-1 and connected medical device networks. The standard helps assign responsibilities; it does not make every device connection acceptable automatically.
What Should Hospitals Ask Before Allowing Supplier Remote Access?
Ask who connects, how access is authenticated, what the session can change, and how the hospital can stop it. Separate routine maintenance from emergency access and from security testing.
See also: Medical Device Remote Access Security: Service and Testing Checklist, and Cybersecurity for Genomic Sequencing and Diagnostic Systems.
Request named accounts rather than shared credentials where the product supports them. Define the approval process, session duration, privilege level, and logging location. Ask whether access reaches only the intended device or also exposes other hospital systems.
A separate cellular connection still creates an access path to the connected product. Review it as part of the device architecture even when it does not traverse the hospital's main network. Network independence is not the same as clinical authorization.
The manufacturer should explain what happens when the service connection fails or credentials are revoked. The hospital should identify who can approve reconnection and whether clinical operation continues without that service.
Our medical device remote access security checklist separates product controls, hospital permissions, and security-test arrangements. It is a decision aid, not a claim that one access architecture fits every installation.
How Should a Small Hospital Handle Device Patches and Downtime?
Use the manufacturer's applicability and release information to plan changes around clinical risk. A component CVE does not establish that every installed device using that component is exploitable.
Ask whether the affected version is present, whether the vulnerable feature is reachable, and what mitigation is supported. Request the expected clinical impact of the mitigation and the update procedure. The hospital needs a practical implementation decision, not just a severity label.
Do not install third-party patches, change device software, or add tools without checking manufacturer instructions and the hospital's change process. An office-computer update procedure may not be suitable for a regulated device.
Build downtime plans around specific clinical dependencies. State how staff obtain results, monitor patients, transfer care, or use alternate equipment when the connected workflow is unavailable. Identify the person who decides that normal service can resume.
Test restoration in an appropriate environment. A backup is useful only if the hospital knows what it contains, who can restore it, and how the restored configuration relates to the approved device setup. The manufacturer's release and recovery records support that decision.
What Evidence Should Manufacturers Give Small Hospital Buyers?
Manufacturers should provide a short, release-specific security package that answers deployment and maintenance questions. It should not force a small hospital to infer operational instructions from a full FDA submission.
Include supported connectivity, secure configuration instructions, remote service controls, update and recovery procedures, vulnerability contacts, and support boundaries. Share component and test information through an appropriate disclosure process.
An MDS2 can organize supplier answers. It is a voluntary disclosure form, not a certification, penetration test, or FDA clearance document. See how hospitals use the MDS2 for the distinction.
The package should identify assumptions. If the device relies on network time, a local server, or a hospital-managed certificate, state who supplies and maintains it. Explain which product functions are unavailable when that dependency fails.
Do not promise that an FDA decision will settle hospital procurement. A hospital still evaluates local deployment, privacy, contracting, and clinical use. The useful handoff translates product evidence into those questions without making new claims about performance.
Read the hospital security review journey to see how manufacturer evidence supports that separate review.
How Blue Goat Cyber Approaches This
Blue Goat works on medical device product security and manufacturer evidence. Our role is not a general hospital help desk, managed network service, or replacement for a hospital's clinical engineering team.
We help manufacturers describe product interfaces, trust boundaries, security controls, and release-specific findings. Threat modeling considers how misuse or compromise could affect device functions. Penetration testing evaluates security behavior within an agreed scope, separate from the manufacturer's general verification and validation work.
For hospital-facing questions, we connect existing product evidence to supported deployment, maintenance, and vulnerability communication. The manufacturer owns its clinical severity decisions, risk acceptance, instructions, and release approval. The hospital owns its local network and clinical operating decisions.
Our medical device cybersecurity consulting supports manufacturer programs and premarket evidence. Hospital procurement information should be consistent with that work, not copied from a generic checklist. Where a requested fact is unavailable, the answer should identify the missing evidence and the person responsible for supplying it.
Frequently Asked Questions
What does cybersecurity for small hospitals mean for medical devices?
It means protecting the clinical functions that depend on connected devices with controls the hospital can maintain. Begin with device ownership, software releases, network dependencies, supplier access, and downtime procedures. Obtain manufacturer-supported configuration and maintenance information. Device security is part of the hospital's wider cybersecurity program, but ordinary office IT controls should not be installed on medical equipment without checking their suitability.
Are HHS cybersecurity goals mandatory for small hospitals?
The Healthcare and Public Health Cybersecurity Performance Goals are voluntary. They help prioritize safeguards, but they do not replace applicable HIPAA obligations, contracts, or other legal requirements. They are also not an FDA submission checklist. Hospital leaders should review each obligation separately and document how device-specific controls fit their operating environment, available staff, and clinical change process.
Does FDA clearance mean a device is safe on any hospital network?
No. An FDA decision does not remove the need to evaluate the hospital's deployment. Manufacturers provide supported configurations, security instructions, and maintenance information. Hospitals assess their own network paths, clinical dependencies, service access, and response procedures. A configuration outside the documented conditions may introduce risks that were not covered by the manufacturer's evidence or supported operating instructions.
Can a hospital scan or penetration-test a device in clinical use?
Do not treat clinical use as authorization for security testing. Scanning and attack testing can interrupt device operation or connected workflows. Establish permission, scope, equipment, clinical safeguards, and recovery arrangements before testing. Use an appropriate nonclinical environment where possible. The hospital, manufacturer, and testing team should agree who can stop testing and how potential clinical effects will be avoided.
Is an SBOM enough to approve a medical device purchase?
No. An SBOM identifies software components, but it does not establish exploitability, clinical risk, or the suitability of the hospital's installation. Review it alongside supported configuration, vulnerability notices, patch plans, service controls, and product support information. A purchase decision also includes clinical, privacy, and contractual considerations. Component transparency supports those reviews rather than replacing their owners or conclusions.
CTA
Preparing device security information for hospital buyers? Start with the hospital security review journey. Compare your current release documents with deployment, remote access, update, and recovery questions. Keep unanswered items visible so the manufacturer and hospital can assign owners before installation rather than relying on assumptions.
About the author

Christian Espinosa, MBA · Founder & CEO, Blue Goat Cyber
U.S. Air Force Academy graduate and veteran with 30+ years in cybersecurity. Founded Alpine Security in 2014 (acquired 2020), then Blue Goat Cyber in 2022. Blue Goat track record: 275+ FDA submissions supported, zero cybersecurity rejections. Author of three books including The Smartest Person in the Room. Ironman triathlete and mountaineer.
Sources & references
Primary sources cited in this article. Links open in a new tab.
